Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring

BACKGROUND: Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. SABR is an established treatment for both primary and secondary liver malignancies, and technological advances have improved it...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Lee, Yoo Young Dominique, Nguyen, Doan Trang, Moodie, Trevor, O’Brien, Ricky, McMaster, Anne, Hickey, Andrew, Pritchard, Nicole, Poulsen, Per, Tabaksblat, Elizaveta Mitkina, Weber, Britta, Worm, Esben, Pryor, David, Chu, Julie, Hardcastle, Nicholas, Booth, Jeremy, Gebski, Val, Wang, Tim, Keall, Paul
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2021
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8091536/
https://ncbi.nlm.nih.gov/pubmed/33941111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08184-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia